TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RADX Stock 12 Month Forecast
Average Price Target
$20.33
▲(270.31% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Radiopharm Theranostics Limited Sponsored ADR in the last 3 months. The average price target is $20.33 with a high forecast of $30.00 and a low forecast of $15.00. The average price target represents a 270.31% change from the last price of $5.49.
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +6.50% per trade.
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +10.48% per trade.
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +10.44% per trade.
trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +10.44% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RADX Analyst Recommendation Trends
Rating
Jul 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
7
8
9
7
8
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
8
9
7
8
In the current month, RADX has received 8Buy Ratings, 0Hold Ratings, and 0Sell Ratings. RADX average Analyst price target in the past 3 months is 20.33.
Each month's total comprises the sum of three months' worth of ratings.
RADX Financial Forecast
RADX Earnings Forecast
Next quarter’s earnings estimate for RADX is -$2.00 with a range of -$2.00 to -$2.00. The previous quarter’s EPS was -$1.95. RADX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RADX has Performed in-line its overall industry.
Next quarter’s earnings estimate for RADX is -$2.00 with a range of -$2.00 to -$2.00. The previous quarter’s EPS was -$1.95. RADX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RADX has Performed in-line its overall industry.
RADX Sales Forecast
Next quarter’s sales forecast for RADX is $1.21M with a range of $1.21M to $1.21M. The previous quarter’s sales results were $1.43M. RADX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RADX has Performed in-line its overall industry.
Next quarter’s sales forecast for RADX is $1.21M with a range of $1.21M to $1.21M. The previous quarter’s sales results were $1.43M. RADX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RADX has Performed in-line its overall industry.
RADX Stock Forecast FAQ
What is RADX’s average 12-month price target, according to analysts?
Based on analyst ratings, Radiopharm Theranostics Limited Sponsored ADR’s 12-month average price target is 20.33.
What is RADX’s upside potential, based on the analysts’ average price target?
Radiopharm Theranostics Limited Sponsored ADR has 270.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RADX a Buy, Sell or Hold?
Radiopharm Theranostics Limited Sponsored ADR has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Radiopharm Theranostics Limited Sponsored ADR’s price target?
The average price target for Radiopharm Theranostics Limited Sponsored ADR is 20.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.00 ,the lowest forecast is $15.00. The average price target represents 270.31% Increase from the current price of $5.49.
What do analysts say about Radiopharm Theranostics Limited Sponsored ADR?
Radiopharm Theranostics Limited Sponsored ADR’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of RADX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.